Alyeska Investment Group
AGTC

Alyeska Investment Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Alyeska Investment Group’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,827
Closed -$481K – 544
2014
Q3 		$481K Buy
+25,827
New +$468K 0.01% 360
2014
Q2 		– Sell
-66,579
Closed -$999K – 473
2014
Q1 		$999K Buy
+66,579
New +$983K 0.03% 295

Other funds holding AGTC

RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group's AGTC Position: Q4 2014 in Review

Alyeska Investment Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2014, closing a stake of 25,827 shares — an estimated $481K sold.

Alyeska Investment Group first reported a position in AGTC in Q1 2014 and held it in 2 quarters. The position peaked at $999K in Q1 2014. 48 funds tracked by Wall St. Rank hold AGTC as of Q4 2014.

  • Alyeska Investment Group reported no remaining Applied Genetic Technologies Corporation position as of Q4 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 25,827 Applied Genetic Technologies Corporation shares in Q4 2014, an estimated $481K.
  • Alyeska Investment Group first reported a position in Applied Genetic Technologies Corporation in Q1 2014 and held it in 2 quarters.
  • Alyeska Investment Group's Applied Genetic Technologies Corporation position peaked at $999K in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2014.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.